BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 24287555)

  • 21. A 17-year retrospective study of institutional results for eye plaque brachytherapy of uveal melanoma using (125)I, (103)Pd, and (131)Cs and historical perspective.
    Leonard KL; Gagne NL; Mignano JE; Duker JS; Bannon EA; Rivard MJ
    Brachytherapy; 2011; 10(4):331-9. PubMed ID: 21349775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bilateral simultaneous primary choroidal melanomas: Treated with palladium-103 plaque radiation.
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Sep; 28(5):NP1-NP5. PubMed ID: 29575936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regression patterns of choroidal melanoma: After palladium-103 (
    Maheshwari A; Finger PT
    Eur J Ophthalmol; 2018 Nov; 28(6):722-730. PubMed ID: 29788760
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
    Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
    Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microwave thermoradiotherapy for uveal melanoma: results of a 10-year study.
    Finger PT
    Ophthalmology; 1997 Nov; 104(11):1794-803. PubMed ID: 9373109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regression Patterns of Iris Melanoma after Palladium-103 (
    Chaugule SS; Finger PT
    Ophthalmology; 2017 Jul; 124(7):1023-1030. PubMed ID: 28377036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Palladium 103 (103Pd) plaque radiation therapy for circumscribed choroidal hemangioma with retinal detachment.
    Aizman A; Finger PT; Shabto U; Szechter A; Berson A
    Arch Ophthalmol; 2004 Nov; 122(11):1652-6. PubMed ID: 15534126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of central vision and macular structure in patients undergoing iodine-125 brachytherapy for ciliochoroidal melanoma.
    Oliver SC; Young TA; Kobe LH; Leu MY; Lee SP; Chun MW; Straatsma BR
    Am J Clin Oncol; 2008 Oct; 31(5):488-92. PubMed ID: 18838887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas.
    Nag S; Quivey JM; Earle JD; Followill D; Fontanesi J; Finger PT;
    Int J Radiat Oncol Biol Phys; 2003 Jun; 56(2):544-55. PubMed ID: 12738332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 125I plaque brachytherapy for anterior uveal melanomas.
    Lumbroso-Le Rouic L; Charif Chefchaouni M; Levy C; Plancher C; Dendale R; Asselain B; Solignac S; Mazal A; Desjardins L
    Eye (Lond); 2004 Sep; 18(9):911-6. PubMed ID: 15002010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outcomes of proton radiation therapy for peripapillary choroidal melanoma at the BC Cancer Agency.
    Tran E; Ma R; Paton K; Blackmore E; Pickles T
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1425-31. PubMed ID: 22209152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
    Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
    Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Long-term results of cobalt 60 curietherapy for uveal melanoma].
    Bacin F; Kwiatkowski F; Dalens H; Rozan R; Gagyi S; Donnarieix D; Bard JJ; Robert JL
    J Fr Ophtalmol; 1998 May; 21(5):333-44. PubMed ID: 9759427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proton beam therapy of parapapillary choroidal melanoma.
    Riechardt AI; Cordini D; Willerding GD; Georgieva I; Weber A; Seibel I; Lakotka N; Bechrakis NE; Foerster MH; Moser L; Joussen AM
    Am J Ophthalmol; 2014 Jun; 157(6):1258-65. PubMed ID: 24548873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of eye-conserving treatment with Ruthenium(106) brachytherapy for choroidal melanoma.
    Verschueren KM; Creutzberg CL; Schalij-Delfos NE; Ketelaars M; Klijsen FL; Haeseker BI; Ligtenberg SM; Keunen JE; Marijnen CA
    Radiother Oncol; 2010 Jun; 95(3):332-8. PubMed ID: 20416963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ruthenium plaque radiation therapy for iris and iridociliary melanomas.
    Razzaq L; Keunen JE; Schalij-Delfos NE; Creutzberg CL; Ketelaars M; de Keizer RJ
    Acta Ophthalmol; 2012 May; 90(3):291-6. PubMed ID: 20670343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Retrospective analysis of ruthenium-106 brachytherapy for small and medium-sized malignant melanoma of the posterior choroid].
    Stoffelns BM; Kutzner J; Jochem T
    Klin Monbl Augenheilkd; 2002 Apr; 219(4):216-20. PubMed ID: 12022004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Extraocular muscle repositioning and diplopia: associated with ophthalmic plaque radiation therapy for choroidal melanoma.
    Nagendran ST; Finger PT; Campolattaro BN
    Ophthalmology; 2014 Nov; 121(11):2268-74. PubMed ID: 25062940
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endoresection versus iodine-125 plaque brachytherapy for the treatment of choroidal melanoma.
    Caminal JM; Mejia K; Masuet-Aumatell C; Arias L; Piulats JM; Gutierrez C; Pera J; Catala J; Rubio M; Arruga J
    Am J Ophthalmol; 2013 Aug; 156(2):334-342.e1. PubMed ID: 23677135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.